Management of gestational diabetes mellitus

Diabetes, Metabolic Syndrome and Obesity

Volumn 2, Issue , 2009, Pages 73-82

  Lapolla, Annunziata ^a   Dalfrà, Maria Grazia ^a   Fedele, Domenico ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Fetal complications; Gestational diabetes; Glucose management; Maternal complications; Obstetric management

Indexed keywords

INSULIN ASPART; INSULIN LISPRO;

DIET RESTRICTION; DRUG SAFETY; EXERCISE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN RESISTANCE; METABOLIC REGULATION; PATIENT CARE; PREGNANCY DIABETES MELLITUS; REVIEW;

EID: 77953404915     PISSN: None     EISSN: 11787007     Source Type: Journal    
DOI: 10.2147/dmsott.s3407     Document Type: Review

References (102)

1. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183-1197.
2. Langer O. Type 2 diabetes in pregnancy: exposing deceptive appearances. J Matern Fetal Neonatal Med. 2008;21(3): 181-189.
3. American Diabetes Association. Gestational Diabetes Mellitus (Position Statement). Diabetes Care. 2004;27(Suppl 1):S88-S90.
4. Ryan EA, Enns L. Role of gestational hormones in the induction of insulin resistance. J Clin Endocrinol Metab. 1988;67:341-347.
5. Kuhl C. Etiology and pathogenesis of gestational diabetes. Diabetes Care. 1998;21:B19-B26.
6. Lapolla A, Dalfrà MG, Mello G, et al. Early detection of insulin sensitivity and beta cell function with simple tests indicate future derangements in late pregnancy. J Clin Endocrinol Metab. 2008;93(3):876-880.
7. Pedersen J. The Pregnant Diabetic and her Newborn. 2nd ed. Munksgaard: Copenhagen and Williams and Wilkins: Baltimore; 1977:211.
8. Casey BM, Lucas MJ, McIntire DD, Leveno KJ. Pregnancy outcomes in women with gestational diabetes compared with the general obstetric population. Obstet Gynaecol. 1997;90:869-873.
9. Kjos AL, Buchanan TA. Gestational diabetes mellitus. N Engl J Med. 1999;341:1749-1756.
10. Langer O. Management of obesity in GDM:old habits die hard. J Matern Fetal Neonatal Med. 2008:21(3):165-171.
11. Kim C, Newton KM, Knoop RH. Gestational diabetes and the incidence of type 2 diabetes. Diabetes Care. 2002;25:1862-1868.
12. Scott DA, Loveman E, McIntire L, Waugh N. Screening for gestational diabetes: a systematic review and economic evaluation. Health Technol Assess. 2002;6(11):1-172.
13. Hunter DJS, Milner R. Gestational diabetes and birth trauma. Am J Obstet Gynecol. 1985:152:918-919.
14. Tuffnell DJ, West J, Walkinshaw SA. Treatments for gestational diabetes and impaired glucose tolerance in pregnancy. The Cochrane Library 2008;(4):1-30.
15. Hiller TA, Vesco KK, Pedula KL, Beil TL, Whitlock EP, Pettitt DJ. Screening for gestational diabetes mellitus: a systematic review for the US Preventive Service Task Force. Ann Intern Med. 2008;148:766-775.
16. Langer O, Yogev Y, Most O, Xenachis EM. Gestational diabetes: the consequences of not treating. Am J Obstet Gynaecol. 2005;192:989-997.
17. Crowther CA, Hiller JE, Moss AJ, Jeffries WS, Robinson JS; for the Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. New Engl J Med. 2005;352(24): 2477-2486.
18. Moss JR, Crowther CA, Hiller JE, Willson KJ, Robinson JS; for the Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Costs and consequences of treatment for mild gestational diabetes mellitus-evaluation from the ACHOIS randomised trial.BMC Pregnancy Childbirth. 2007;7:27-33.
19. National Institute for Health and Clinical Excellence. Cost-effectiveness of screening, diagnosis and treatment for gestational diabetes. March 2008; Appendix D:165-190.
20. Langer O. Gestational diabetes: the consequences of not treating. In: M Hod, L Jovanovic, GC Di Renzo, A DeLeiva, O Langer, eds. Textbook of Diabetes and Pregnancy. 2nd ed. Informa Healthcare; 2008;107-117.
21. Metzer BE; Buchanan TA, Coustan DR, et al. Summary and Recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care. 2007;30(2): S251-S260.
22. Metzger BE, Coustan DM. Organizing Committee: Summary and Recommendations of the Fourth International Workshop Conference on Gestational Diabetes Mellitus. Diabetes Care. 1998;21 (Suppl 2): B161-167.
23. Gilmer MD, Beard RW, Brooke FM, Oakley NW. Carbohydrate metabolism in pregnancy. Part 1: diurnal plasma glucose profile in normal and diabetic women. Br Med J. 1975;3:399-402.
24. Cousins L, Rigg L, Hollingsworth D, Brink G, Aurand J, Yen SS. The 24-hour excursion and diurnal rhythm glucose, insulin and C-peptide in normal pregnancy. Am J Obstet Gynecol.1980;136:483-488.
25. Phelps RL, Metger BE, Freinkel N. Carbohydrate metabolism in pregnancy. XVII. Diurnal profiles of plasma glucose, insulin, free fatty acids, triglycerides, cholesterol, and individual amino acids in late normal pregnancy. Am J Obstet Gynecol. 1981;140:730-736.
26. Parretti E, Mecacci F, Papini M, et al. Third trimester maternal glucose levels from diurnal profiles in non diabetic pregnancies: correlation with sonographic parameters of foetal growth. Diabetes Care. 2001;24:1319-1323.
27. Yogev Y, Ben-Haroush A, Chen R, Rosenn B, Hod M, Langer O. Diurnal glycemic profile in obese and normal weight non diabetic pregnant women. Am J Obstet Gynecol. 2004;191:949-953.
28. R in healthy pregnant women and determination of cut-off values. E J Obstet Gynaecol Reprod Biol. 2008;139:46-52.
29. Langer O, Yogev Y, Xenakis EMJ, Brustman L. Overweight and obese in gestational diabetes: the impact on pregnancy outcome. AM J Obstet Gynaecol. 2005;192:1768-1776.
30. Jovanovic-Peterson L, Peterson CM, Reed GF, et al. Maternal postprandial glucose levels and infant birth weight: Diabetes in Early Pregnancy Study: The National Institute of Child Health and Human Development -Diabetes in Early Pregnancy Study. Am J Obstet Gynecol. 1991;164:103-111.
31. De Veciana M, Major CA, Morgan MA, et al. Post prandial versus pre prandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med. 1995;333:1237-1241.
32. Ben-Haroush A, Yogev Y, Chen R, Rosen B, Hod M, Langer O. The postprandial glucose profile in the diabetic pregnancies. Am J Obstet Gynecol. 2004;191:576-581.
33. Leguizamon G, Krupitzki H, Glujovsky D, Olivera Ravasi M, Reece EA. Blood glucose monitoring in gestational diabetes mellitus:1-versus 2-h blood glucose determinations. J Matern Fetal Neonatal Med. 2002;12:384-388.
34. Langer O, Mazze R. The relationship between large for gestational age infants and glycemic control in women with gestational diabetes. Am J Obstet Gynecol. 1988;159:1478-1483.
35. Langer O. Prevention of macrosomia. Baillieres Clin Obstet Gynaecol. 1991;5:333-347.
36. Pettitt DJ, Knowless WC, Baird HR, Bennett PH. Gestational diabetes: infant and maternal complications of pregnancy in relation to third trimester glucose tolerance in Pima Indians. Diabetes Care. 1980;3: 458-464.
37. Bartha JL, Martinez-Del-Fresno P, Comino-Delgado R. Gestational diabetes mellitus diagnosed during early pregnancy. Am J Obstet Gynaecol. 2000;182:346-350.
38. Aberg A, Rydhstrom H, Kallen B, Kallen K.Impaired glucose tolerance during pregnancy is associated with increased fetal mortality in preceding sibs. Acta Obstet Gynecol Scand 1997;76:212-217.
39. Beischer NA, Wein P, Sheedy MT, Steffen B. Identification and treatment of women with hyperglycemia diagnosed during pregnancy can significantly reduce perinatal mortality rates. Aust N Z J Obstet Gynaecol. 1996;182:239-247.
40. Karlson K, Kjellmer I. The outcome of diabetic pregnancies in relation to the mother's blood sugar level. Am J Obstet Gynaecol. 1972;112: 213-220.
41. Langer O, Rodriguez DA, Xenachis EMJ, McFarland MB, Berkus MD, Arrendono MD. Intensified versus conventional management of gestational diabetes. Am J Obstet Gynaecol. 1994;170: 1036-1047.
42. Langer O. A spectrum of glucose thresholds may effectively prevent complications in the pregnant diabetic patients. Semin Perinatol. 2002;26:196-205.
43. The HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcome. N Engl J Med. 2008;358(19): 1991-2002.
44. Chen R, Yogev Y, Ben-Haroush A, Jovanovic L, Hod M, Philip M. Continuous glucose monitoring for the evaluation and improved control of gestational diabetes mellitus. J Matern Fetal Neonatal Med. 2003;14:256-260.
45. Kerssen A, deValk HW, Visser GHA. Day-to-day glucose variability during pregnancy in women with type 1 diabetes mellitus: glucose profiles measured with the continuous glucose monitoring. BJOG. 2004;11:919-924.
46. Taslimi MM, Navabi K, Acosta R, Helmer A, El-Sayed YY. Concealed maternal blood glucose excursions correlate with birth weight centile. J Diab Science Technol. 2008;2(3):456-460.
47. Mosca A, Paleari R, Dalfrà MG, et al. Reference intervals for haemoglobin A1c in pregnant women: data from an Italian Multicentric study. Clin Chem. 2006;52:1138-1143.
48. Wyse LJ, Jones M, Mandel F. Relationship of glycosylated hemoglobin, fetal macrosomia and birthweight macrosomia. Am J Perinatol. 1994;11:260-262.
49. 1c results improve the accuracy of sonographic diagnosis of macrosomia? Ultrasound Obstet Gynaecol. 2004;23:466-471.
50. 1c levels are significantly lower in early and late pregnancy. Diabetes Care. 2004;5:1200-1201.
51. 1c measurements: a consensus statement. Diabet Med. 2000;17:5-6.
52. ACOG Practice Bulletin Clinical Management Guidelines for Obstetrician-Gynaecologists. No 30. Obstet Gynaecol. 2001:98(3): 525-538.
53. European Association of Perinatal Medicine (EAPM). Diabetes and pregnancy update and guidelines. Hod M, Carrapato M, Eds, 2000.
54. Garner P, Okun N, Keely E, et al. A randomised controlled trial of strict glycemic control and tertiary level obstetric care versus routine obstetric care in the management of gestational diabetes: a pilot study. Am J Obstet Gynaecol. 1997;177:190-195.
55. Landon MB, Thom E, Spong CY, et al. The National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network randomized clinical trial in progress. Diabetes Care. 2007;30(Suppl 2):S194-S199.
56. Larciprete G, Valensise H, Vasapollo B, et al. Fetal subcutaneous tissue thickness (SCTT) in healthy and gestational diabetic pregnancies. Ultrasound Obstet Gynecol. 2003;22:591-597.
57. Ben-Haroush A, Yogev Y, Hod M. Fetal weight estimation in diabetic pregnancies and suspected fetal macrosomia. J Perinat Med. 2004;32:113-121.
58. Colman A, Maharaj D, Hutton J, Tuohy J. Reliability of ultrasound estimation of fetal weight in term singleton pregnancies. NZ Med J. 2006;119:U2146.
59. Benacerraf BR, Gelman R, Frigoletto FD. Sonographically estimated fetal weights: accuracy and limitation. Am J Obstet Gynecol. 1988;159:1118-1121.
60. Predanic M, Cho A, Ingrid F, Pellettieri J. Ultrasonographic estimation of fetal weight. J Ultrasound Med. 2002;21:495-500.
61. Sherman DJ, Arieli S, Tovbin J, Siegel G, Caspi E, Bukovsky I. A comparison of clinical and ultrasonic estimation of fetal weight. Obstetrics and Gynecology. 1998;91(2):212-217.
62. Kernaghan D, Ola B, Fraser RB, Farrell T, Owen P. Fetal size and growth velocity in the prediction of the large for gestational age (LGA) infant in a glucose impaired population. Eur J Obstet Gynecol Reprod Biol. 2007 Jun; 132(2):189-192. Epub 2006 Aug 22.
63. Pates JA, McIntire DD, Casey BM, Leveno KJ. Predicting macrosomia. J Ultrasound Medicine. 2008;27:39-43.
64. Uotila J, Dastidar P, Heinonen T, Rymin P, Punnonen R, Laasonen E. Magnetic resonance imaging compared to ultrasonography in fetal weight and volume estimation in diabetic and normal pregnancy. Acta Obstet Gynecol Scand. 2000;79:255-259.
65. Lee W, Deter RL, Emersole JD, Huang R, Blanckaert K, Romero R: Birth weight prediction by three-dimensional ultrasonography: fractional limb volume. J Ultrasound Med. 2001;20:1283-1292.
66. Meizner I, Mashiach R. Sonography in diabetic pregnancies. In: Hod M, Jovanovic L, Di Renzo GC, DeLeiva A, Langer O, eds. Textbook of Diabetes and Pregnancy. 2nd ed.Informa Healthcare; 2008; 253-258.
67. Schaefer-Graf UM, Kios SL, Fauzan OH, et al. A randomized trial evaluating a predominantly fetal growth-based strategy to guide management of gestational diabetes in Caucasian women. Diabetes Care. 2004;27:297-302.
68. Bonomo M, Cetin I, Pisoni MP, et al. Flexible treatment of gestational diabetes modulated on ultrasound evaluation of intrauterine growth: a controlled randomized clinical trial. Diab Metab. 2004;30: 237-243.
69. Abramowicz JS, Sarosh R, Abramowicz S. Fetal cheek-to-cheek diameter in the prediction mode of delivery. Am J Obstet Gynaecol. 2005;192:1205-1213.
70. Bernstein IM, Catalano PM. Influence of foetal fat on the ultrasound estimation of foetal weight in diabetic mothers. Obstet Gynaecol. 1992;79:561-563.
71. Parretti E, Carignani I, Cioni R, et al. Sonographic evaluation of fetal growth and body composition in women with different degrees of normal glucose metabolism. Diabetes Care. 2003;26:2741-2748.
72. Reader D, Splett P, Gunderson E. Impact of gestational diabetes mellitus nutrition practice guidelines implemented by registered dieticians on pregnancy outcome. J Am Diet Assoc. 2006;106:1426-1433.
73. Food and Nutrition Board. Nutrition during pregnancy. Part 1:weight gain. Part 2: nutrient supplements. Washington DC: Institute of Medicine, National Academy of Sciences; 1990.
74. Knoop RH, Magee MS, Raisys V, Benetti T. Metabolic effects of hypocaloric diets in management of gestational diabetes. Diabetes. 1991;40(Suppl 2):165-171.
75. Magee MS, Knopp RH, Benedetti TJ. Metabolic effects of 1200 kcal diet in obese pregnant women with gestational diabetes. Diabetes. 1990;34:234-240.
76. Rizzo T, Metger BE, Burns WJ. Correlations between antepartum maternal metabolism and child intelligence. N Engl J Med. 1991;325: 911-916.
77. Rae A, Bond D, Evans S, North F, Robertman B, Walters B. A randomized controlled trial of dietary energy restriction in the management of obese women with gestational diabetes. Aust NZJ Obstet Gyn. 2000;40:416-422.
78. Algert S, Shragg P, Hollingsworth DR. Moderate caloric restriction in obese women with gestational diabetes. Obstet Gynaecol. 1985;65: 487-491.
79. Gillen l, Tapsell LC, Martin GS. The type and frequency of consumption of carbohydrate-rich foods may play a role in the clinical expression of insulin resistance during pregnancy. Nutrition and Dietetics. J Diet Assoc Australia. 2002;59(2):135-143.
80. Nolan J. Improved glucose tolerance in gestational diabetic women on a low fat, high unrefined carbohydrate diet. Aust N Zel J Obstet Gynaecol. 1984;24(3):174-177.
81. Ceysens G, Rouiller D, Boulvain M. Exercise for diabetic pregnant women. Cochrane Database Syst. Rev 3, CD004225(2006).
82. Dyck R, Klomp H, Tan L, Turnell RW, Boctor MA. A comparison of rates, risk factors and outcomes of gestational diabetes between aboriginal and non aboriginal women in the Saskatoon health district. Diabetes Care. 2002;25:487-493.
83. Dempsey J, Butler C, Sorensen TK, et al. A case-control study of maternal recreational physical activity and risk of gestational diabetes mellitus. Diab Res Clin Pract. 2004;66:203-215.
84. American Diabetes Association. Medical management of pregnancy complicated by diabetes. ADA Clinical Education Series. 3rd ed. 2000;126-128.
85. Lapolla A, Dalfrà MG, Fedele D. Insulin therapy in pregnancy complicated by diabetes: are insulin analogs a new tool? Diabetes Metab Res Rev. 2005;21:241-252.
86. Di Cianni G, Torlone E, Lencioni E, et al. Perinatal outcomes associated with the use of glargine during pregnancy. Diabet Med. 2008; 25:993-996.
87. Boskovic R, Feig DS, Derewlany L, Knie B, Portnoi G, Koren G. Transfer of insulin across the human placenta: in vitro perfusion studies. Diabetes Care. 2003;26(5):1390-1394.
88. Jovanovic J, Ilic S, Pettitt DJ, et al. Metabolic and immunologic effects of insulin lispro in gestational diabetes. Diabetes Care. 1999;22:1422-1427.
89. Pettitt DJ, Ospina P, Howard C, Zisser H, Jovanovic L. Efficacy, safety and lack of immunogenicity of insulin aspart compared with regular human insulin for women with gestational diabetes mellitus. Diabetic Medicine. 2007;24:1129-1135.
90. Hofmann T, Horstmann G, Stammberger I. Evaluation of the reproductive toxicity and embryotoxicity of insulin glargine (Lantus) in rats and rabbits. Int J Toxicol. 2002;21(3):181-189.
91. Price N, Bartlett G, Gillmer MD. Use of insulin glargine during pregnancy: a case-control pilot study. BJOG. 2007;114:453-457.
92. Elliot BD, Langer O, Schenker S, Johnson RD, Prihoda T. Comparative placental transport of oral hypoglycemic agents in humans: a model of human placental drug transfer. Am J Obstet Gynaecol. 1994;171: 653-660.
93. Langer O, Yogev Y, Xenachis EMJ, Rosenn B. Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome. Am J Obstet Gynaecol. 2005;192:134-139.
94. Holt RI, Clarke P, Parry E C, Coleman MAG. The effectiveness of glibenclamide in women with gestational diabetes. Diabetes Obes Metab. 2008;10:906-911.
95. Jacobson GF, Ramos GA, Ching JY, Kirby RS, Ferrara A, Field DR. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. Am J Obstet Gynaecol. 2005;193:118-124.
96. Hague WM, Davoren PM, McIntyre D, Norris R, Xiaonian X, Charles B. Metformin crosses the placenta: a modulator for fetal insulin resistance? BMJ. 4 December 2003.
97. Rowan JA, Hague WM, Gao W, Battin MR, Moore MP; for the MIG Trial Investigators. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008;358:2003-2015.
98. Glueck CJ, Wang P, Kobayashi S, Phillips H, Sieve-Smith L. Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril. 2002;77(3):520-525.
99. Glueck CJ, Goldenberg N, Pranikoff J, Loftspring M, Sieve L, Wang P. Height, weight and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy. Hum Reprod. 2004;19(6):1323-1330.
100. de Veciana M,Trail PA, Lau TK, Dulaney K. A comparison of oral acarbose and insulin in women with gestational diabetes mellitus. Obstet Gynecol.2002;99:5S.
101. Chan LY,Yeung JH, Lau TK. Placental transfer of rosiglitazone in the first trimester of human pregnancy. Fert Steril 2005;83:955-958.
102. Hiles RA, Bawdon RE, Petrella EM. Ex vivo human placental transfer of the peptides pramlintide and exenatide. Hum Exp Toxicol. 2003;22(12):623-628.